Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
28
CRNX Quote, Financials, Valuation and Earnings
Last price:
$53.63
Seasonality move
:
-9.59%
Day range:
$51.73 - $54.25
52-week range:
$33.67 - $62.53
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
5.96x
Volume:
1.8M
Avg. volume:
753.6K
1-year change:
55.12%
Market cap:
$5B
Revenue:
$4M
EPS (TTM):
-$3.73
CRNX Analysts' Consensus Rating
The 9 analysts providing 12-month price projections for Crinetics Pharmaceuticals shares anticipate an average target of $75.07, ranging from a low estimate of $55.00 to a high estimate of $97.00. This average target implies a growth of 40.32% compared to the current stock price of $53.50.
Consensus Price Target
$75.07
Highest Price Target
$97.00
Lowest Price Target
$55.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 8 | 8 | 8 |
| Hold | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Buy | Buy |
CRNX Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
